This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

reputable news agency

proofread

Black patients more likely to experience MACE after ADT for prostate cancer

Black patients more likely to experience MACE after ADT for prostate cancer

Black patients are more likely to experience adverse cardiovascular outcomes after systemic androgen deprivation therapy (ADT) for prostate cancer, according to a study published online June 18 in JACC: CardioOncology.

Biniyam G. Demissei, M.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues conducted a retrospective cohort study involving 3,543 prostate cancer patients treated with systemic ADT between 2008 and 2021. The multivariable adjusted association between self-reported race (Black versus White) and incident major adverse cardiovascular events (MACE) after initiation of ADT was assessed.

The researchers found that the risk for MACE was increased in association with Black race (hazard ratio, 1.38), with the strongest associations seen for incident heart failure, , and (hazard ratios, 1.79, 1.98, and 1.76, respectively). Overall, 98% of the disparity in MACE risk between Black and White patients was mediated by the social vulnerability index, specifically the socioeconomic status theme.

"Multilevel targeted interventions tailored to the needs of patients from socioeconomically vulnerable communities are necessary to reduce the disparities in CVD in patients with ," the authors write.

One author disclosed ties to Pfizer.

More information: Biniyam G. Demissei et al, Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer, JACC: CardioOncology (2024). DOI: 10.1016/j.jaccao.2024.04.004

Edward Christopher Dee et al, Disparities in Cardio-Oncology Care Among Patients With Prostate Cancer, JACC: CardioOncology (2024). DOI: 10.1016/j.jaccao.2024.05.005

© 2024 HealthDay. All rights reserved.

Citation: Black patients more likely to experience MACE after ADT for prostate cancer (2024, June 20) retrieved 24 June 2024 from https://medicalxpress.com/news/2024-06-black-patients-mace-adt-prostate.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Risks for major adverse cardiovascular events, mortality lower after surgery for hyperthyroidism

0 shares

Feedback to editors